<SEC-DOCUMENT>0001558370-23-007172-index.html : 20230428
<SEC-HEADER>0001558370-23-007172.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428090018
ACCESSION NUMBER:		0001558370-23-007172
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20230615
FILED AS OF DATE:		20230428
DATE AS OF CHANGE:		20230428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Corvus Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001626971
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464670809
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37719
		FILM NUMBER:		23860671

	BUSINESS ADDRESS:	
		STREET 1:		863 MITTEN ROAD
		STREET 2:		SUITE 102
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
		BUSINESS PHONE:		(650) 900-4520

	MAIL ADDRESS:	
		STREET 1:		863 MITTEN ROAD
		STREET 2:		SUITE 102
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tmb-20230615xdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: tmb-20230615xdef14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tmb-20230615xdef14a_a001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: tmb-20230615xdef14a_a001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20230615xdef14a_a012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: tmb-20230615xdef14a_a012.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tmb-20230615xdef14a_a013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tmb-20230615xdef14a_a013.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tmb-20230615xdef14a_bg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tmb-20230615xdef14a_bg001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tmb-20230615xdef14a_bg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: tmb-20230615xdef14a_bg002.jpg

</DOCUMENT>
</SEC-DOCUMENT>